Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | ITGAV | P06756 | 1/20 | 0.30 |
| ▸ | VNN1 | O95497 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4754993 | 0.83 | HCAR2 (0.48) | HCAR2ATMALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL2491694 | 0.74 | ALDH1A1 (0.59) | HCAR2ATMALDH1A1MAPK1 | |
| SCHEMBL30267575 | 0.73 | HCAR2 (0.56) | HCAR2ATMALDH1A1CYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL30054224 | 0.72 | ALDH1A1 (0.57) | HCAR2ATMALDH1A1MAPK1 | |
| SCHEMBL27773928 | 0.72 | VNN1 (0.33) | HCAR2CYP2C9VNN1 | |
| SCHEMBL1020413 | 0.71 | TSHR (0.56) | ALDH1A1MAPK1KMT2A | |
| SCHEMBL1478348 | 0.70 | HCAR2 (0.52) | HCAR2ATMALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL27698129 | 0.70 | HCAR2 (0.52) | HCAR2ATMALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL17962588 | 0.69 | HCAR2 (0.46) | HCAR2ATMALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL10149368 | 0.69 | TPMT (0.46) | ATMCYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008059519-A2 | A PROCESS FOR THE PREPARATION OF INTERMEDIATES OF ROSUVASTATIN | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2008-05-22 | — | — | WO | disclosed |